GLIMECHECK M2

Glimecheck M2 Tablet is a fixed-dose combination of Glimepiride 2 mg and Metformin Hydrochloride 500 mg, formulated to provide enhanced glycemic control in patients with Type 2 Diabetes Mellitus. This dual-action oral antidiabetic medication is especially useful for patients who are inadequately controlled on monotherapy.

• Glimepiride stimulates pancreatic insulin secretion.

• Metformin reduces hepatic glucose production and improves insulin sensitivity.

This combination helps maintain consistent blood sugar levels throughout the day while minimizing the risk of complications associated with uncontrolled diabetes.

Key Benefits:

• Combines insulin secretion and sensitivity improvement

• Controls both fasting and postprandial glucose levels

• Reduces the risk of diabetic complications

• Well-suited for moderate to severe Type 2 diabetes